COMMUNIQUÉS West-GlobeNewswire

RTI Surgical Completes Acquisition of Collagen Solutions
01/11/2024
RTI Surgical Completes Acquisition of Collagen Solutions ALACHUA, Fla., November 1, 2024 – RTI Surgical ("RTI" or "the Company"), a leading CDMO pushing the boundaries of innovation and tissue engineering to meet [...]
Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control
01/11/2024
FemBloc issued patent provides additional coverage for Femasys’ therapeutic option for women seeking permanent birth control ATLANTA, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical [...]
Galecto Reports Third Quarter 2024 Financial Results
01/11/2024
- Completed strategic review to focus on oncology and severe liver diseases - Announced acquisition of global rights to BRM-1420, a dual ENL-YEATS and FLT3 inhibitor for multiple genetic subsets of AML from Bridge [...]
Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial
01/11/2024
DENVER, Nov. 01, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on [...]
Novo Nordisk A/S: Semaglutide 2.4 mg demonstrates superior improvement in both liver fibrosis and MASH resolution in the ESSENCE trial
01/11/2024
Bagsværd, Denmark, 1 November 2024 – Novo Nordisk today announced the headline results from part 1 of the ongoing ESSENCE trial, a pivotal phase 3, 240-week, double-blinded trial in 1,200 adults with metabolic [...]
TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update
01/11/2024
Conference call to be held Monday, November 4, 2024, at 8:30 AM ET NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Monday November 4 [...]
Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024
01/11/2024
BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]
The MUHC Foundation and the Beat 92.5’s Raise Craze raises $95,000 to help strike out breast cancer
01/11/2024
All funds are supporting breast cancer care at the McGill University Health Centre (MUHC) MONTREAL, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The MUHC Foundation, in collaboration with The Beat 92.5 and Pink in the City, raised [...]
L’événement Raise Craze de la Fondation du CUSM et de The Beat 92.5 recueille 95 000 $ pour aider à combattre le cancer du sein
01/11/2024
Tous les fonds appuient les soins du cancer du sein au Centre universitaire de santé McGill (CUSM) MONTRÉAL, 01 nov. 2024 (GLOBE NEWSWIRE) -- La Fondation du CUSM, en collaboration avec The Beat 92.5 et Pink in the City [...]
Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML
01/11/2024
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug [...]
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
01/11/2024
CAMBRIDGE, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in [...]
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/11/2024
CLEVELAND, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in [...]
Entourage Health Provides Company Update
01/11/2024
TORONTO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company") , a Canadian producer and distributor of award-winning cannabis products, announced [...]
Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results
01/11/2024
Reports record third quarter 2024 revenue of $7.6 million , representing growth of 24% compared to the third quarter of 2023 Placed seven Growth Direct ® systems in the third quarter of 2024, marking the highest number [...]
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
31/10/2024
SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of its previously announced registered direct offering priced at-the-marker under Nasdaq rules for the [...]
Cognition Therapeutics Presents Poster of Participant Demographics from Phase 2 Dementia with Lewy Bodies Study at CTAD
31/10/2024
- Patient characteristics are consistent with other DLB studies - PURCHASE, N.Y., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company [...]
Supernus Presents Promising Data from Open-Label Phase 2a Study of SPN-820 Data in Major Depressive Disorder at Psych Congress 2024
31/10/2024
Participants in the Phase 2a study experienced rapid and meaningful decreases in depressive symptoms Suicidal ideation decreased by 80% SPN-820 was well-tolerated with few adverse events SPN-820 is a novel, first-in- [...]
INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update
31/10/2024
Company to Host Conference Call Today, October 31, at 4:30pm ET BOCA RATON, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company [...]
LeMaitre Q3 2024 Financial Results
31/10/2024
BURLINGTON, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants, and services, reported Q3 2024 results, announced a $0.16/share quarterly dividend, and provided [...]

Pages